Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is an X-linked disease associated with the expansion of the CAG triplet repeat present in exon 1 of the androgen receptor (AR) gene. This results in the production of a mutant AR containing an elongated polyglutamine tract (polyQ) in its N-terminus. Interestingly, the ARpolyQ becomes toxic only after its activation by the natural androgenic ligands, possibly because of aberrant androgen-induced conformational changes of the ARpolyQ, which generate misfolded species. These misfolded ARpolyQ species must be cleared from motoneurons and muscle cells, and this process is mediated by the protein quality control (PQC) system. Experimental evidence suggested that failure of the PQC pathways occurs in disease, leading to ARpolyQ accumulation and toxicity in the target cells. In this review, we summarized the overall impact of mutant and misfolded ARpolyQ on the PQC system and described how molecular chaperones and the degradative pathways (ubiquitin-proteasome system (UPS), the autophagy-lysosome pathway (ALP), and the unfolded protein response (UPR), which activates the endoplasmic reticulum-associated degradation (ERAD)) are differentially affected in SBMA. We also extensively and critically reviewed several molecular and pharmacological approaches proposed to restore a global intracellular activity of the PQC system. Collectively, these data suggest that the fine and delicate equilibrium existing among the different players of the PQC system could be restored in a therapeutic perspective by the synergic/additive activities of compounds designed to tackle sequential or alternative steps of the intracellular defense mechanisms triggered against proteotoxic misfolded species.

The Role of the Protein Quality Control System in SBMA / Rusmini, Paola; Crippa, Valeria; Cristofani, Riccardo; Rinaldi, Carlo; Cicardi, Maria Elena; Galbiati, Mariarita; Carra, Serena; Bilal, Malik; Greensmith, Linda; Poletti, Angelo. - In: JOURNAL OF MOLECULAR NEUROSCIENCE. - ISSN 0895-8696. - 58:3(2016), pp. 348-364. [10.1007/s12031-015-0675-6]

The Role of the Protein Quality Control System in SBMA

CARRA, Serena;
2016

Abstract

Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is an X-linked disease associated with the expansion of the CAG triplet repeat present in exon 1 of the androgen receptor (AR) gene. This results in the production of a mutant AR containing an elongated polyglutamine tract (polyQ) in its N-terminus. Interestingly, the ARpolyQ becomes toxic only after its activation by the natural androgenic ligands, possibly because of aberrant androgen-induced conformational changes of the ARpolyQ, which generate misfolded species. These misfolded ARpolyQ species must be cleared from motoneurons and muscle cells, and this process is mediated by the protein quality control (PQC) system. Experimental evidence suggested that failure of the PQC pathways occurs in disease, leading to ARpolyQ accumulation and toxicity in the target cells. In this review, we summarized the overall impact of mutant and misfolded ARpolyQ on the PQC system and described how molecular chaperones and the degradative pathways (ubiquitin-proteasome system (UPS), the autophagy-lysosome pathway (ALP), and the unfolded protein response (UPR), which activates the endoplasmic reticulum-associated degradation (ERAD)) are differentially affected in SBMA. We also extensively and critically reviewed several molecular and pharmacological approaches proposed to restore a global intracellular activity of the PQC system. Collectively, these data suggest that the fine and delicate equilibrium existing among the different players of the PQC system could be restored in a therapeutic perspective by the synergic/additive activities of compounds designed to tackle sequential or alternative steps of the intracellular defense mechanisms triggered against proteotoxic misfolded species.
2016
14-nov-2015
58
3
348
364
The Role of the Protein Quality Control System in SBMA / Rusmini, Paola; Crippa, Valeria; Cristofani, Riccardo; Rinaldi, Carlo; Cicardi, Maria Elena; Galbiati, Mariarita; Carra, Serena; Bilal, Malik; Greensmith, Linda; Poletti, Angelo. - In: JOURNAL OF MOLECULAR NEUROSCIENCE. - ISSN 0895-8696. - 58:3(2016), pp. 348-364. [10.1007/s12031-015-0675-6]
Rusmini, Paola; Crippa, Valeria; Cristofani, Riccardo; Rinaldi, Carlo; Cicardi, Maria Elena; Galbiati, Mariarita; Carra, Serena; Bilal, Malik; Greensm...espandi
File in questo prodotto:
File Dimensione Formato  
rusmini2015.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 901.72 kB
Formato Adobe PDF
901.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1074591
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 27
social impact